Published by Josh White on 10th May 2019
(Sharecast News) - Proton therapy developer Advanced Oncotherapy has secured additional financing of £12.345m in the form of a two-year secured debt facility with Credit Suisse for £10m, and a direct subscription raising a total of £2.345m from predominantly Swiss institutional investors, it announced on Friday.